A simple risk score effectively predicted type 2 diabetes in Iranian adult population: Population-based cohort study

European Journal of Public Health

Volumn 21, Issue 5, 2011, Pages 554-559

  Bozorgmanesh, Mohammadreza ^a   Hadaegh, Farzad ^a   Ghaffari, Somayeh ^a   Harati, Hadi ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

diabetes; model; prediction; risk factors; score system

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD; BLOOD PRESSURE; COHORT ANALYSIS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH SERVICES RESEARCH; HUMAN; INCIDENCE; IRAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSIOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; STATISTICAL MODEL;

ADULT; AGED; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEALTH SERVICES RESEARCH; HUMANS; INCIDENCE; IRAN; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; TRIGLYCERIDES;

EID: 80053513157     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckq074     Document Type: Article

References (43)

1. Bozorgmanesh MR, Hadaegh F, Padyab M, et al. Temporal changes in anthropometric parameters and lipid profile according to body mass index among an adult Iranian urban population. Ann Nutr Metab 2008;53:13-22.
2. Hadaegh F, Bozorgmanesh MR, Ghasemi A, et al. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health 2008;8:176.
3. Esteghamati A, Gouya MM, Abbasi M, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 2008; 31:96-8.
4. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-50. (Pubitemid 32378388)
5. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the best predictor of future type 2 diabetes? Diabetes Care 2007;30:1544-8. (Pubitemid 46871168)
6. Schulze MB, Weikert C, Pischon T, et al. Use of multiple metabolic and genetic markers to improve the prediction of type 2 diabetes: the EPIC-Potsdam Study. Diabetes Care 2009;32:2116-9.
7. Hippisley-Cox J, Coupland C, Robson J, et al. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ 2009;338:b880.
8. Kahn HS, Cheng YJ, Thompson TJ, et al. Two risk-scoring systems for predicting incident diabetes mellitus in U.S. adults age 45 to 64 years. Ann Intern Med 2009;150:741-51.
9. Wilson PW, Meigs JB, Sullivan L, et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007;167:1068-74. (Pubitemid 46835795)
10. Mainous AG III, Diaz VA, Everett CJ. Assessing risk for development of diabetes in young adults. Ann Fam Med 2007;5:425-9. (Pubitemid 47535973)
11. von, Eckardstein A, Schulte H, Assmann G. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective cardiovascular munster. J Clin Endocrinol Metab 2000;85:3101-8.
12. Kolberg JA, Jorgensen T, Gerwien RW, et al. Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohort. Diabetes Care 2009;32:1207-12.
13. Schulze MB, Hoffmann K, Boeing H, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 2007;30:510-5. (Pubitemid 46354326)
14. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivariate data for clinical use: the Framingham Study risk score functions. Stat Med 2004;23:1631-60. (Pubitemid 38660414)
15. Cabrera de Leon A, Coello SD, Rodriguez Perez Mdel C, et al. A simple clinical score for type 2 diabetes mellitus screening in the Canary Islands. Diabetes Res Clin Pract 2008;80:128-33.
16. Xianghai Z, Linong J, Yingying L, et al. Risk factors associated with the presence of diabetes in Chinese communities in Beijing. Diabetes Res Clin Pract 2009;86:233-8.
17. Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009;10:5.
18. Hadaegh F, Zabetian A, Harati H, Azizi F. Waist/height ratio as a better predictor of type 2 diabetes compared to body mass index in Tehranian adult men-a 3.6-year prospective study. Exp Clin Endocrinol Diabetes 2006;114:310-5. (Pubitemid 44166178)
19. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.
20. Tirosh A, Shai I, Tekes-Manova D, et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005;353:1454-62. (Pubitemid 41400919)
21. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52. (Pubitemid 37553153)
22. Li C, Ford ES, Meng YX, et al. Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Cardiovasc Diabetol 2008;7:4.
23. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. BMJ 2004;329: 168-9.
24. Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol 2006;163:670-5.
25. Glumer C, Carstensen B, Sandbaek A, et al. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004;27:727-33. (Pubitemid 38280541)
26. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
27. Wilson PWF, Meigs JB, Sullivan L, et al. Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 2007;167:1068-74. (Pubitemid 46835795)
28. Diabetes Prevention Program Research Group. Strategies to identify adults at high risk for type 2 diabetes. Diabetes Care 2005;28:138-44.
29. Zimetbaum P, Frishman WH, Ooi WL, et al. Plasma lipids and lipoproteins and the incidence of cardiovascular disease in the very elderly. The Bronx Aging Study. Arterioscler Thromb 1992;12:416-23.
30. Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 2005;56:303-7. (Pubitemid 41631661)
31. Greenfield MS, Kraemer F, Tobey T, Reaven G. Effect of age on plasma triglyceride concentrations in man. Metabolism 1980;29:1095-9. (Pubitemid 11232206)
32. Berns MAM, De Vries JHM, Katan MB. Determinants of the increase of serum cholesterol with age: a Longitudinal Study. Int J Epidemiol 1988; 17:789-96. (Pubitemid 19042019)
33. Franklin SS, Gustin WIV, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 1997;96:308-15. (Pubitemid 27298437)
34. Nyamdorj R, Qiao Q, Lam TH, et al. BMI compared with central obesity indicators in relation to diabetes and hypertension in Asians. Obesity 2008;16:1622-35. (Pubitemid 351915134)
35. Nyamdorj R, Qiao Q, Soderberg S, et al. BMI compared with central obesity indicators as a predictor of diabetes incidence in Mauritius. Obesity 2009; 17:342-8.
36. Tulloch-Reid MK, Williams DE, Looker HC, et al. Do measures of body fat distribution provide information on the risk of type 2 diabetes in addition to measures of general obesity? Diabetes Care 2003;26:2556-61.
37. Hsieh SD, Yoshinaga H, Muto T. Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 2003;27:610-6. (Pubitemid 36561019)
38. Lorenzo C, Williams K, Stern MP, Haffner SM. Height, ethnicity, and the incidence of diabetes: the San Antonio Heart Study. Metabolism 2009;58:1530-5.
39. Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis 2009;19:401-8.
40. McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139: 802-9.
41. Sumner AE, Finley KB, Genovese DJ, et al. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. Arch Intern Med 2005;165:1395-400. (Pubitemid 40973422)
42. Conen D, Ridker PM, Mora S, et al. Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J 2007;28: 2937-43. (Pubitemid 350233022)
43. McNeely MJ, Boyko EJ, Leonetti DL, et al. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care 2003;26:758-63. (Pubitemid 36929340)